|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current Assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||||
| Inventories | ||||||||||||||||||||
| Deferred costs associated with deferred revenue | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization | ||||||||||||||||||||
| Deposits for financial assurance | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Deferred Tax Assets, Net | ||||||||||||||||||||
| Other long-term assets | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT) | ||||||||||||||||||||
| Current Liabilities | ||||||||||||||||||||
| Accounts payable and accrued liabilities | ||||||||||||||||||||
| Accounts payable under purchase agreements | ||||||||||||||||||||
| Inventories owed to customers and suppliers | ||||||||||||||||||||
| Contract with Customer, Liability, Current | ||||||||||||||||||||
| Convertible senior notes (Predecessor) | ||||||||||||||||||||
| Current debt | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term debt | ||||||||||||||||||||
| Postretirement health and life benefit obligations | ||||||||||||||||||||
| Pension benefit liabilities | ||||||||||||||||||||
| Advances from customers | ||||||||||||||||||||
| Long-term SWU Loans | ||||||||||||||||||||
| Long-term SWU Loan | ||||||||||||||||||||
| Other long-term liabilities | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Preferred Stock, Par Value Per Share | ||||||||||||||||||||
| Series B Preferred Stock | ||||||||||||||||||||
| Total preferred Stock, Par Value Per Share | ||||||||||||||||||||
| Stockholders' Deficit | ||||||||||||||||||||
| Preferred stock | ||||||||||||||||||||
| Series A Preferred Stock | ||||||||||||||||||||
| Preferred Series B | ||||||||||||||||||||
| Total preferred stock | ||||||||||||||||||||
| Common Stock, Shares Authorized | ||||||||||||||||||||
| Common Class A | ||||||||||||||||||||
| Common Class B | ||||||||||||||||||||
| Common Stock, Par or Stated Value Per Share | ||||||||||||||||||||
| Common Stock, Shares, Issued | ||||||||||||||||||||
| Common Class A | ||||||||||||||||||||
| Common Class B | ||||||||||||||||||||
| Total common Stock, Shares, Issued | ||||||||||||||||||||
| Common stock | ||||||||||||||||||||
| Common Class A | ||||||||||||||||||||
| Common Class B | ||||||||||||||||||||
| Excess of capital over par value | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Accumulated other comprehensive income (loss), net of tax | ||||||||||||||||||||
| Stockholders' Equity | ||||||||||||||||||||
| Total Liabilities and Stockholders’ Equity (Deficit) |
Loading...